Skip to main content
Erschienen in: BMC Oral Health 1/2024

Open Access 01.12.2024 | Research

Impact of the COVID-19 pandemic on clinical and psychological aspects of temporomandibular disorders

verfasst von: Seong Hae Kim, Bo Young Jeong, Young Sun Kim, Ji Woon Park

Erschienen in: BMC Oral Health | Ausgabe 1/2024

Abstract

Background

The Coronavirus 2019 disease (COVID-19) caused drastic changes in people’s lifestyle that affected TMD characteristics through its physical and psychological influences. The aim of this study was to define the clinical and psychological characteristics of a large group of well-defined TMD patients and seek their differences between before and during the COVID-19 pandemic to establish points of care to be emphasized in the post-pandemic era.

Methods

TMD patients diagnosed by the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) aged ≥ 18 were analyzed. Samples between September, 2017 to July, 2019 (n = 455) and March, 2021 to June, 2022 (n = 338) were collected to represent before and during COVID-19, respectively. The Graded Chronic Pain Scale (GCPS) and Symptom Checklist-90-Revision (SCL-90-R) were used to evaluate disability levels and psychological status. Clinical indices were compared between COVID periods and factors related to higher pain levels were investigated according to pandemic period.

Results

More patients reported pain on palpation of the masticatory muscles during the pandemic (p = 0.021) while the number decreased for neck muscles (p = 0.001) and TMJ (p < 0.001) areas. Patients reporting nocturnal bruxism (23.3–29.6%) and clenching (45.1–54.7%) significantly increased during the pandemic. TMD patients with pain without disability were more common during the pandemic regardless of pain intensity (p < 0.001). The number of patients expressing interference in daily activities decreased drastically during COVID-19 regardless of disability level (p < 0.001). Factors associated with higher than moderate pain intensity (CPI ≥ 50) were insomnia (odds ratio [OR] = 1.603, p = 0.047) and somatization (OR = 1.082, p < 0.001) before the pandemic. During the pandemic, age (OR = 1.024, p = 0.007), somatization (OR = 1.070, p = 0.006), and paranoid ideation (OR = 1.117, p = 0.003) were significantly associated with higher pain intensity.

Conclusions

The results of our study underline the importance of evaluating psychological profiles of TMD patients, especially somatization, paranoid ideation and psychoticism, in exceptional situations that may cause a change in individual mental status. This will lead to a better understanding of the individual TMD patient and help in planning personalized treatment strategies that will assist the patient in adjusting to changes occurring in special environments such as the COVID-19 pandemic.
Hinweise

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Abkürzungen
TMD
Temporomandibular disorders
TMJ
temporomandibular joints
COVID-19
coronavirus 2019 disease
DC/TMD
diagnostic criteria for temporomandibular disorders
SQ
symptom questionnaire
WHO
World Health organization
GCPS
graded chronic pain scale
CPI
characteristic pain intensity
VAS
visual analog scale
SCL-90-R
symptom checklist-90-revision
PST
positive symptom total
GSI
global severity index
PSDI
positive symptom distress index
SEM
structural equation modeling
CFA
confirmatory factor analysis
SFA
single factor analysis
AVE
average variance extracted
CR
composite reliability
χ2/DF
Chi-square over degrees of freedom
CFI
comparative fit index
RMSEA
root mean square error of approximation
GFI
goodness of fit index
TLI
Tucker-Lewis index
SD
standard deviation
NRS
numeric rating scale
OR
odds ratio
CMO
comfortable mouth opening
MMO
maximum mouth opening
MOL
mouth opening limitation
SOM
somatization
O-C
obsessive-compulsive
I-S
interpersonal sensitivity
DEP
depression
ANX
anxiety
HOS
hostility
PHOB
phobic anxiety
PAR
paranoid ideation
PSY
psychoticism

Background

Temporomandibular disorders (TMD) is characterized by dysfunction and pain of the temporomandibular joints (TMJ), masticatory muscles, and surrounding structures. The prevalence of TMD in the general population has been reported as approximately 5–12% with women showing twice the risk compared to men [1, 2]. Although the etiology of TMD has not been clearly identified, previous research has shown that psychological factors such as anxiety and depression play a major role in its occurrence and prognosis [3]. Painful TMD showed increased associations with bronchitis and asthma as with widespread pain in adolescents. Also, those with painful TMD reported a higher number of systemic conditions compared to those free of TMD [4].
In November 2019, Coronavirus 2019 disease (COVID-19) broke out in Wuhan, China, rapidly spreading worldwide. The main symptoms of infected patients ranged from mild headaches to severe respiratory problems which led to death [5]. The World Health Organization (WHO) declared COVID-19 a pandemic in March, 2020 after which most governments implemented social distancing and partial to overall lockdown to prevent further spread of the virus. Decrease in social interactions with the rise of health threats, difficulty in accessing medical facilities, and income declines due to economic instability were among the many changes that affected people both physically and mentally. Not only did the majority of people fail to meet others and fulfill their social responsibilities, but also the fear of death and illness was prevalent [6, 7].
Studies reported that the incidence of musculoskeletal dysfunction and pain increased with COVID-19 infection [8] and 45.1% of patients still showed symptoms of musculoskeletal pain post-COVID recovery with de novo pain presenting in many [9]. Furthermore, research on orofacial pain conditions showed a high prevalence of TMD symptoms [10] and also twice the risk of TMD events in COVID-19 patients [11]. Recent research showed that chronic TMD patients with were more sensitive to distress caused by the pandemic and their psychological alterations resulted in increased orofacial pain levels [12]. As literature suggests, TMD is a complex disorder that is influenced by various biological, psychological, and social factors, all which were impacted by the pandemic condition and could have acted as health risks. Unfortunately, most related studies consisted of relatively small sample sizes and were based on results from online surveys and questionnaires.
Therefore, the aim of this study was to define the clinical and psychological characteristics of two large independent groups of well-defined TMD patients and seek their differences according to COVID-19 pandemic period to assess its influence on disease characteristics. Also, further analysis was done to investigate clinical indices that were closely related to TMD of higher pain levels in each pandemic period to define points of care to be emphasized in the post-pandemic era and their role in the biopsychosocial model of TMD.

Materials and methods

Subjects

Data was collected from consecutive “first-visit” patients over the age of 18 who were diagnosed by a single oral medicine specialist based on the Diagnostic Criteria for Temporomandibular Disorders (DC/TMD) between September, 2017 to June, 2022 [13].
A minimum of 105 patients per group was deemed necessary to attain a statistical power of 95% with an alpha error of 0.05 and a medium effect size for a two-tailed independent-samples t-test determined with G*Power software (version 3.1.9.7). A target sample size of 500 consecutive patients was set to enhance statistical accuracy and representativeness [14]. Finally, 455 and 338 patients each were included to represent the before (Sept 2017 to Jul 2019) and during COVID-19 (Mar 2021 to Jun 2022) period after excluding those with incomplete questionnaires and missing clinical information. The remaining numbers in each group were sufficient to allow adequate power of verification based on sample size estimation. The study was reviewed by the Institutional Review Board of Seoul National University Dental Hospital (reference number ERI22028). All subjects signed an informed consent form on their first visit approving the usage of their medical records for academic purposes. The need for obtaining further informed consent was waived by the Institutional Review Board based on the retrospective nature of the study.

Assessment of clinical and psychological characteristics

Clinical indices including comfortable and maximum mouth opening range (mm), pain on palpation of the TMJ, masticatory and cervical muscle areas were recorded. The presence of tooth attrition, tongue, and buccal mucosa riding was verified through intraoral examinations. The Symptom Questionnaire (SQ) was used to collect comprehensive data on pain and related factors of TMD [13]. Parafunctional habits and oral behaviors were evaluated based on self-report.
The Graded Chronic Pain Scale (GCPS) version 2 was used to measure TMD pain severity and disability levels. Characteristic Pain Intensity (CPI) was calculated as the average of worst, present, and average pain intensity during the past month on a 0–10 visual analog scale (VAS) multiplied by 10. Interference level due to TMD pain was assessed with a 0–10 VAS.
Symptom Checklist-90-Revision (SCL-90-R), a self-report psychometric instrument, was applied for psychological evaluation [15].

Statistical analysis

All analyses were performed after normality tests using Kolmogorov-Smirnov test. Independent t-test and Mann-Whitney U test was used for continuous variables and Chi-square test for discrete variables. Multiple regression and logistic regression analyses were done to determine variables associated with increased pain based on CPI scores. SPSS 25 (IBM SPSS Statistics Version 25.0. Armonk, NY: IBM Corp) was used in the analysis described above. For visualization of correlation analysis, ANACONDA (Anaconda, Inc., Texas, USA) was used with SPSS 25. Structural Equation Modeling (SEM) was used to evaluate the contribution of SCL-90-R sub-scores on GCPS variables. AMOS 26 (IBM AMOS Statistics Version 26.0. Armonk, NY: IBM Corp) was used to analyze the model. Before testing SEM, confirmatory factor analysis (CFA) was used to verify whether the single factor analysis (SFA) constructed as sub-items of the GCPS was suitable. An ideal model is determined when the average variance extracted (AVE) ≥ 0.5 [16] and the composite reliability (CR) ≥ 0.7 [17]. The reliability of the SFA model for before COVID-19 was AVE = 0942, CR = 0.980, and for during COVID-19 AVE = 0.882, CR = 0.957. With the latent variable in the center, each item of the SCL-90-R was used as a measurement variable on the left, and the measured GCPS variable was depicted on the right. Additionally, age and gender were added as independent variables to compensate for differences in variables based on the two items. Chi-square over degrees of freedom (χ2/DF), comparative fit index (CFI), root mean square error of approximation (RMSEA), goodness of fit index (GFI), and Tucker-Lewis index (TLI) were applied in determining the goodness of fit of SEM. The criteria for good fit were χ2/DF < 5, CFI, GFI, TLI > 0.9, RMSEA < 0.06 [1820]. The level of significance was set α = 0.05 and a 95% confidence level.

Results

Clinical characteristics according to COVID-19 period

The average age of the total 793 participants was 37.6 years (14.9 standard deviation [SD]), of which 561 (70.7%) were women. As shown in Table 1, more patients reported pain on palpation of the masticatory muscles during the pandemic (p = 0.021) while the number decreased for neck muscles (p = 0.001) and TMJ (p < 0.001) areas. Patients showing TMJ noises, both click (p < 0.001) and crepitus (p < 0.001) increased during the pandemic. Joint locking showed a significant decrease (p < 0.001). Patients reporting nocturnal bruxism (23.3–29.6%) and clenching (45.1–54.7%) significantly increased during the pandemic.
Table 1
Clinical characteristics according to COVID-19 period
 
Pre-COVID19 (n = 455)
During-COVID19 (n = 338)
Total
(n = 793)
P-value
Age§
33.0 (27.0, 47.0)
32.0 (26.0, 45.0)
33.0 (26.0, 46.0)
0.155
Sex
Male
130 (28.6%)
102 (30.2%)
232 (29.3%)
0.623
Female
325 (71.4%)
236 (69.8%)
561 (70.7%)
Initial NRS§
4.0 (3.0, 6.0)
4.0 (2.0, 6.0)
4.0 (3.0, 6.0)
0.325
CMO (mm)
39.3 (11.0)
39.0 (11.3)
39.2 (11.1)
0.719
MMO (mm)
43.7 (9.5)
43.1 (9.7)
43.4 (9.6)
0.410
MOL (MMO ≤ 40)
125 (27.5%)
103 (30.5%)
228 (28.8%)
0.356
Pain on mouth opening
223 (49.0%)
183 (54.1%)
406 (51.2%)
0.153
Palpation
Masticatory muscles
255 (56.0%)
217 (64.2%)
472 (59.5%)
0.021*
Neck muscles
141 (31.0%)
69 (20.4%)
210 (26.5%)
0.001*
TMJ
167 (36.7%)
79 (23.4%)
246 (31.0%)
< 0.001*
Sound
Click
103 (22.6%)
167 (49.4%)
270 (34.0%)
< 0.001*
Crepitus
38 (8.4%)
62 (18.3%)
100 (12.6%)
< 0.001*
Joint locking
118 (25.9%)
13 (3.8%)
131 (16.5%)
< 0.001*
Tooth attrition
166 (36.5%)
77 (22.8%)
243 (30.6%)
< 0.001*
Tongue ridging
242 (53.2%)
164 (48.5%)
406 (51.2%)
0.194
Mucosal ridging
305 (67.0%)
193 (57.1%)
498 (62.8%)
0.004*
Contributing factors
Bruxism
106 (23.3%)
100 (29.6%)
206 (26.0%)
0.046*
Clenching
205 (45.1%)
185 (54.7%)
390 (49.2%)
0.007*
Perioral contraction
63 (13.8%)
46 (13.6%)
109 (13.7%)
0.924
Tongue thrusting
27 (5.9%)
24 (7.1%)
51 (6.4%)
0.508
Insomnia
135 (29.7%)
89 (26.3%)
224 (28.2%)
0.302
NRS, numerical rating scale; CMO, Comfortable mouth opening; MMO, maximum mouth opening; MOL, mouth opening limitation; TMJ, temporomandibular joint
Differences between groups were tested with Independent T-test: mean (SD)
Differences between groups were tested with chi-square test: number of subjects or positive answers (%)
§Differences between groups were tested with Mann-Whitney U test: median (25%, 75%)
*Significant difference, p < 0.05

Disability level and psychological conditions according to COVID period

As shown in Table 2, TMD patients with pain without disability were more common during the pandemic regardless of pain intensity (p < 0.001). The number of patients expressing interference in daily activities decreased drastically during COVID-19 regardless of disability level (p < 0.001). The level of current pain showed a significant decrease in mean (3.4 to 3.0). Interference level and days experiencing interference all decreased during COVID-19. The results of SCL-90-R are shown in Table 3. Depression was the dimension with most patients showing high scores indicating pathologic status both before and during the pandemic.
Table 2
Pain and disability level according to COVID-19 period
 
Pre-COVID19 (n = 455)
During-COVID19 (n = 338)
Total
(n = 793)
P-value
Grade
No disability (0)
72 (15.8%)
46 (13.6%)
118 (14.9%)
< 0.001*
Low intensity pain
without disability (I)
121 (26.6%)
155 (45.9%)
276 (34.8%)
High intensity pain
without disability (II)
66 (14.5%)
103 (30.5%)
169 (21.3%)
Moderately limiting (III)
120 (26.4%)
29 (8.6%)
149 (18.8%)
Severely limiting (IV)
76 (16.7%)
5 (1.5%)
81 (10.2%)
CPI
40.0 (20.0, 60.0)
40.0 (19.3, 57.0)
40.0 (20.0, 60.0)
0.399
CPI ≥ 50
186 (40.9%)
124 (36.7%)
310 (39.1%)
0.231
Current pain
3.0 (1.0, 5.0)
3.0 (1.0, 5.0)
3.0 (1.0, 5.0)
0.025*
Worst pain
5.0 (2.0, 7.0)
5.0 (2.8, 7.0)
5.0 (2.0, 7.0)
0.403
Average pain
4.0 (1.0, 6.0)
3.0 (1.0, 5.0)
3.0 (1.0, 6.0)
0.243
Number of days of pain
15.0 (3.0, 51.0)
15.0 (3.0, 50.0)
15.0 (3.0, 50.0)
0.877
Interference level
Daily activity
3.0 (1.0, 5.0)
2.0 (0.0, 5.0)
3.0 (0.0, 5.0)
0.001*
Social
3.0 (0.0, 5.0)
2.0 (0.0, 4.0)
2.0 (0.0, 5.0)
< 0.001*
Work activity
3.0 (0.0, 5.0)
1.0 (0.0, 4.0)
2.0 (0.0, 5.0)
< 0.001*
Number of days with interference
7.0 (0.0, 30.0)
0.0 (0.0, 1.0)
0.0 (0.0, 15.0)
< 0.001*
CPI, characteristic pain intensity
Differences between groups were tested with chi-square test: number of subjects or positive answers (%)
Differences between groups were tested with Mann-Whitney U test: median (25%, 75%)
* Significant difference, p < 0.05
Table 3
Psychological characteristics according to COVID-19 period
 
Pre-COVID19 (n = 455)
During-COVID19 (n = 338)
Total
(n = 793)
P-value
Depression
40.0 (36.0, 47.0)
41.0 (37.0, 48.0)
41.0 (36.0, 48.0)
0.387
Anxiety
40.0 (38.0, 46.0)
40.0 (38.0, 46.0)
40.0 (38.0, 46.0)
0.681
Somatization
43.0 (39.0, 48.0)
43.0 (40.0, 48.0)
43.0 (40.0, 48.0)
0.918
Obsessive-compulsive
42.6 (8.9)
42.4 (8.5)
42.5 (8.7)
0.735
Interpersonal sensitivity
41.0 (36.0, 46.0)
41.0 (37.0, 46.0)
41.0 (37.0, 46.0)
0.279
Hostility
40.0 (40.0, 45.0)
42.0 (40.0, 45.0)
40.0 (40.0, 45.0)
0.131
Phobic anxiety
42.0 (40.0, 45.0)
42.0 (40.0, 45.0)
42.0 (40.0, 45.0)
0.990
Paranoid ideation
38.0 (38.0, 42.0)
39.5 (38.0 45.0)
38.0 (38.0, 42.0)
0.104
Psychoticism
40.0 (38.0, 44.0)
40.0 (38.7, 45.0)
40.0 (38.0, 45.0)
0.362
Differences between groups were tested with Mann-Whitney U test: median (25%, 75%).
Differences between groups were tested with Independent T-test: mean (SD).
* Significant difference, p < 0.05.

Correlations among clinical and psychological variables according to COVID period

Figure 1 shows results from Spearman’s correlation analysis as heatmap with darker blue indicating higher correlation (coefficient closer to -1.0 or 1.0) and whiter a coefficient closer to 0. Before the pandemic, somatization scores from SCL-90-R showed a significant correlation with pain intensity based on a 0–10 numeric rating scale (NRS) (r = 0.239, p < 0.001), disability days (r = 0.205, p < 0.001), and CPI (r = 0.267, p < 0.001). During the pandemic, somatization scores showed significant correlation with CPI (r = 0.269, p < 0.001) and pain intensity NRS (r = 0.214, p < 0.001). Unlike before the pandemic, paranoid ideation also showed significant correlation with CPI (r = 0.203, p < 0.001).
Multiple regression analysis was conducted using clinical and psychological variables to determine their effect on pain intensity based on CPI. Somatization was found to be the only variable showing a consistent positive relationship with pain intensity in both periods (p < 0.001).
Results from logistic regression analysis are shown in Table 4. Factors associated with higher than moderate pain intensity (CPI ≥ 50) were insomnia (odds ratio [OR] = 1.608, p = 0.041) and somatization (OR = 1.080, p < 0.001) before the pandemic. During the pandemic, age (OR = 1.020, p = 0.023), somatization (OR = 1.072, p = 0.004), and paranoid ideation (OR = 1.121, p = 0.002) were significantly associated with higher pain intensity.
Table 4
Psychological indices associated with moderate to severe pain according to COVID-19 period
 
Variable
OR
95% CI
p-value
Lower
Upper
Pre-
COVID19
(n = 455)
Age
1.005
0.992
1.018
0.453
Sex
1.480
0.931
2.351
0.097
Insomnia
1.608
1.019
2.537
0.041*
Depression
0.940
0.893
0.991
0.020*
Anxiety
0.980
0.923
1.040
0.503
Somatization
1.080
1.041
1.120
< 0.001*
Interpersonal Sensitivity
1.016
0.972
1.063
0.486
Paranoid Ideation
0.977
0.926
1.031
0.400
Psychoticism
1.058
0.982
1.139
0.139
During-COVID19 (n = 338)
Age
1.020
1.003
1.037
0.023*
Sex
0.886
0.509
1.541
0.668
Insomnia
0.920
0.511
1.657
0.782
Depression
1.062
0.997
1.132
0.060
Anxiety
1.027
0.959
1.099
0.452
Somatization
1.072
1.023
1.123
0.004*
Interpersonal Sensitivity
0.947
0.891
1.006
0.078
Paranoid Ideation
1.121
1.043
1.204
0.002*
Psychoticism
0.903
0.831
0.982
0.018*
The results were obtained from logistic regression analysis
Moderate to severe pain: characteristic pain intensity ≥ 50
Reference group for statistical comparisons: Sex = male and contributing factors = negative
*Significant difference: p < 0.05
The results of SEM analysis are shown in Fig. 2. Both before COVID-19 (chi-square = 37.225; DF = 22; CMIN/DF = 1.692; GFI = 0.989; TLI = 0.990; CFI = 0.998; RMSEA = 0.039 [0.015 − 0.060]) and during COVID-19 model (chi-square = 36.131; DF = 22; CMIN/DF = 1.642; GFI = 0.986; TLI = 0.983; CFI = 0.996; RMSEA = 0.044 [0.014 − 0.068]) showed good fit. Somatization (p < 0.001) significantly affected pain intensity based on GCPS before COVID-19. During COVID-19, somatization (p < 0.001), interpersonal sensitivity (p = 0.006), and depression (p = 0.012) significantly affected pain intensity. In both periods, the effect of each item of SCL-90-R on pain intensity was low with the highest factor loading of 0.36.

Discussion

The main goal of this retrospective study was to compare clinical characteristics of TMD patients before and during the pandemic and to investigate risk factors associated with higher pain intensity according to COVID-19 period. The results of this study showed that there were changes in clinical characteristics of TMD during the COVID-19 pandemic. More patients reported pain on palpation of the masticatory muscles while fewer patients reported pain on TMJ area palpation during the pandemic. At the same time, more patients reported the presence of nocturnal bruxism and tooth clenching. Those experiencing pain regardless of intensity increased during the pandemic while those reporting disability due to TMD decreased. Different psychological conditions were associated with moderate to severe TMD pain during the pandemic indicating a change in the influence of psychological factors on TMD pain characteristics.
The patients who sought care during the lockdown presented more masticatory muscle pain, TMJ sounds, and self-reported parafunctional habits than those who attended before the pandemic. These findings were corroborated by aggravation of TMD symptoms and oral parafunction reported during the COVID-19 pandemic in previous literature [21]. Patients showed greater rates of myalgia, headache, and degenerative joint disease during the pandemic than those who visited before. They also had significantly more pain-related and intra-articular TMD conditions [22]. A study on rheumatoid arthritis patients also reported a significant increase in the prevalence of fibromyalgia and disease activity during the pandemic compared to pre-COVID-19 periods [23]. However, the results of our analysis showed that fewer patients reported pain on TMJ and cervical muscle palpation during the pandemic. The consequences of COVID-19-related musculoskeletal pain symptoms are not yet fully understood and diverse physiological processes have been proposed to be associated with a wide range of clinical symptoms [24]. Our result is congruous to an Italian study showing that the prevalence of TMD pain and joint sounds incremented in correlation with gender, age, and stress level during the pandemic [25]. TMJ noise is the most common symptom in TMD patients. However, its intensity does not show a direct positive association with pain nor functional limitation levels of TMD. TMJ noises may be identified as an early sign of TMD and as the disease progresses into degenerative joint disease [26]. Previous studies have shown that patients with oral parafunctions had a higher prevalence of TMJ noise compared to those without [27]. Studies have also presented a correlation between nocturnal bruxism and the diagnosis of TMD [28]. Parafunctional habits are considered to be involved in peripheral mechanisms which are likely to play a part in TMD onset while the chronification of TMD symptoms is more likely to depend on central components including sensitization and genetic factors. Bruxism is generally considered as innocuous unless the forces exerted in addition to other aggravating factors outpace physiological resilience and result in elevated risk of structural change and deep pain input [29]. As the global health emergency had been ongoing for three years, people’s mental stress has increased due to concerns about infection and social distancing. Since mental stress is known to have a negative effect on oral parafunctions the significant increase of bruxism observed in our TMD patients during the COVID-19 outbreak could be a direct result of deteriorating mental health. Accumulated psychological distress can induce sympathetic activity which leads to the release of endogenous steroids, promoting vasoconstriction of muscles and increase in peripheral vascular resistance [30]. Increased sympathetic signals and hyperarousal can account for sleep deprivation as well, which may heighten mental stress levels to create a vicious cycle [31]. Since oral parafunction was not investigated objectively the increased level of parafunctional habits observed in this study may be interpreted as a result of an increase in patient awareness during the daytime. Psychosocial factors including perceived stress, depression, and anxiety have been proposed to generate awake bruxism [32, 33].
Those experiencing pain regardless of intensity (GCPS grade 1,2) increased during the pandemic while those who answered that pain hinders their lives decreased significantly. These results are supported by other papers that have explored the impact of pain experiences and mood disasters during COVID-19. Adjusted coping strategies including increased exercise in the lockdown period could lower pain severity and interference level [34]. Another prior study depicted that the social disability domain improved post-pandemic however, the results were limited to female TMD patients [7]. On the other hand, there are studies that report increase in pain interference in the majority of a pain patient group with social distancing [35]. Studies on pain interference during the pandemic based on GCPS are limited, so it is difficult to directly compare our results with those based on different assessment tools. Fewer occupational activities and increased work-from-home status during the pandemic may be related to the improvement in pain interference scores of our study. Another research concluded that the COVID-19 situation did not affect pain intensity or health-related quality of life emphasizing the importance of individual skills in handling chronic pain [36]. In case of certain conditions such as endometriosis, chronic pain symptoms and global physical impairment even improved post lockdown [37].
Contrary to a recent review reporting a high prevalence of negative psychiatric symptoms during the pandemic [38] and several studies showing COVID-19 to have a considerable negative impact on emotional status which prompted an exacerbation of bruxism and TMD symptoms [39] no significant change was found in our TMD patients before and during COVID-19. The current investigation found a difference in psychological characteristics associated with moderate to severe pain before (depression and somatization) and during (paranoid ideation, psychoticism, and somatization) the pandemic. Somatization consistently predicted painful TMD in both periods. Patients with painful TMD often exhibit moderate to high levels of somatization [40, 41]. Somatization is more prevalent in TMD patients compared to the general population [42]. Also, it is known to predict chronic and widespread pain even without organic disease [43]. Somatization was more prevalent among bruxers and was the only variable that demonstrated a significant correlation with the diagnosis of myofascial pain [44]. Another study reported the association between severe somatization and high interference levels [45]. The positive correlation between pain intensity and paranoid ideation post COVID-19 lockdown might imply pain catastrophizing or maladaptive cognitive measures implemented by patients suffering from moderate to severe pain [46]. The overall results of our study showing increase in those reporting masticatory muscle pain and the consistent association of somatization with moderate to severe pain underline the need of both biological and psychosocial methods to be applied in the evaluation and treatment of TMD for best results. And cardinal psychological and social aspects of TMD are prone to change depending on the presence of specific surrounding conditions [47].
There are several limitations to consider when interpreting the results. All patients in this present study consisted of South Koreans and specific ethnic and cultural factors may have influenced the results and limited its generalizability. Further research comparing results from different countries and ethnic backgrounds may provide valuable data on the impact of the COVID-19 pandemic on TMD characteristics. Secondly, due to the retrospective nature of the study, possibilities of sampling bias exist. However, the total sample size is relatively large compared to other studies on TMD and the patient group was defined based on a well-standardized diagnostic process supporting the reliability of the results. Still, the OR for factors associated with higher than moderate intensity pain are relatively small indicating weak association. Also, investigations were conducted only for a limited period of time during the COVID-19 pandemic. Future studies should be designed to include a longer research period which would have allowed better understanding of the longitudinal impact of the ongoing COVID-19 pandemic. Thirdly, some clinical parameters relied on self-report thus, lacking objectivity. Further research including psychological assessment done by trained experts are needed to elucidate the correlation between pain intensity and mental health in TMD under pandemic conditions. Finally, the study consisted of two independent cohorts of patients from before and during the pandemic analyzed each in a cross-sectional manner. The study design does not allow the evaluation of causation but only differences between the cohorts due to COVID-19. To identify causality, future studies should follow the change in disease characteristics of an identical group of patients before and after the pandemic.

Conclusion

TMD symptoms including masticatory muscle pain, TMJ noise, and parafunctional habits increased during the pandemic compared to pre-COVID-19. On the other hand, subjective pain interference decreased, which implies the importance of individual coping strategies. Somatization emerged as the sole predictor of pain intensity both before and during the pandemic while different psychological aspects were associated with moderate to severe TMD pain according to the pandemic period. Mental health affects individual coping and management strategies in adverse times. The results of our study underline the importance of evaluating psychological profiles, especially somatization, paranoid ideation and psychoticism, of TMD patients in exceptional situations that may cause a change in individual mental status. This will lead to a better understanding of the individual TMD patient and help in planning personalized treatment strategies that will assist the patient in adjusting to the changes occurring in special environments such as the COVID-19 pandemic.

Acknowledgements

Not applicable.

Declarations

All methods were performed in accordance with the Declaration of Helsinki and relevant guidelines and regulations. This work was approved by the Institutional Review Board of Seoul National University Dental Hospital (ERI22028). All subjects signed an informed consent form on their first visit approving the usage of their medical records for academic purpose. The need for obtaining further informed consent was waived by the Institutional Review Board based on the retrospective nature of the study.
Not applicable.

Competing interests

The authors have no competing interests to declare in relation to this work.
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://​creativecommons.​org/​licenses/​by/​4.​0/​. The Creative Commons Public Domain Dedication waiver (http://​creativecommons.​org/​publicdomain/​zero/​1.​0/​) applies to the data made available in this article, unless otherwise stated in a credit line to the data.

Publisher’s Note

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Literatur
11.
Zurück zum Zitat Tirrell M, Katz J. Increased occurrence of temporomandibular joint disorders in COVID-19 confirmed patients. Am J Dent. 2021;34(6):313–6.PubMed Tirrell M, Katz J. Increased occurrence of temporomandibular joint disorders in COVID-19 confirmed patients. Am J Dent. 2021;34(6):313–6.PubMed
13.
Zurück zum Zitat Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for Temporomandibular disorders (DC/TMD) for clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache. 2014;28(1):6–27. https://doi.org/10.11607/jop.1151.CrossRefPubMed Schiffman E, Ohrbach R, Truelove E, et al. Diagnostic criteria for Temporomandibular disorders (DC/TMD) for clinical and Research Applications: recommendations of the International RDC/TMD Consortium Network* and Orofacial Pain Special Interest Group†. J Oral Facial Pain Headache. 2014;28(1):6–27. https://​doi.​org/​10.​11607/​jop.​1151.CrossRefPubMed
15.
Zurück zum Zitat Derogatis LR, Kathryn L. The SCL-90-R and brief Symptom Inventory (BSI) in primary care. Handbook of psychological assessment in primary care settings. Routledge; 2000. pp. 310–47. Derogatis LR, Kathryn L. The SCL-90-R and brief Symptom Inventory (BSI) in primary care. Handbook of psychological assessment in primary care settings. Routledge; 2000. pp. 310–47.
16.
Zurück zum Zitat Mulaik SA, James LR, Van Alstine J, Bennett N, Lind S, Stilwell CD. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105(3):430.CrossRef Mulaik SA, James LR, Van Alstine J, Bennett N, Lind S, Stilwell CD. Evaluation of goodness-of-fit indices for structural equation models. Psychol Bull. 1989;105(3):430.CrossRef
17.
Zurück zum Zitat Fornell C. Larcker. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18(1):39–50.CrossRef Fornell C. Larcker. Evaluating structural equation models with unobservable variables and measurement error. J Mark Res. 1981;18(1):39–50.CrossRef
18.
Zurück zum Zitat Fornell C, Bookstein FL. Two structural equation models: LISREL and PLS applied to consumer exit-voice theory. J Mark Res. 1982;19(4):440–52.CrossRef Fornell C, Bookstein FL. Two structural equation models: LISREL and PLS applied to consumer exit-voice theory. J Mark Res. 1982;19(4):440–52.CrossRef
19.
Zurück zum Zitat Tucker LR. A reliability coefficient for maximum likelihood factor analysis. Psychometrika. 1973;38(1):1–10.CrossRef Tucker LR. A reliability coefficient for maximum likelihood factor analysis. Psychometrika. 1973;38(1):1–10.CrossRef
20.
Zurück zum Zitat Schermelleh-Engel K, Moosbrugger H, Hans Müller. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res Online. 2003;8(2):23–74. Schermelleh-Engel K, Moosbrugger H, Hans Müller. Evaluating the fit of structural equation models: tests of significance and descriptive goodness-of-fit measures. Methods Psychol Res Online. 2003;8(2):23–74.
21.
Zurück zum Zitat Winocur-Arias O, et al. Painful temporomandibular disorders, bruxism and oral parafunctions before and during the COVID-19 pandemic era: a sex comparison among dental patients. J Clin Med. 2022;11(3):589.CrossRefPubMedPubMedCentral Winocur-Arias O, et al. Painful temporomandibular disorders, bruxism and oral parafunctions before and during the COVID-19 pandemic era: a sex comparison among dental patients. J Clin Med. 2022;11(3):589.CrossRefPubMedPubMedCentral
22.
Zurück zum Zitat Yap A, Ujin, et al. The influence of the COVID-19 pandemic, sex, and age on temporomandibular disorders subtypes in east Asian patients: a retrospective observational study. BMC Oral Health. 2023;23(1):1–9.CrossRef Yap A, Ujin, et al. The influence of the COVID-19 pandemic, sex, and age on temporomandibular disorders subtypes in east Asian patients: a retrospective observational study. BMC Oral Health. 2023;23(1):1–9.CrossRef
23.
Zurück zum Zitat Upadhyaya S, Kumar et al. Fibromyalgia and mental health in rheumatoid arthritis: a cross-sectional prevalence study from the COVID-19 pandemic. BMJ open 13.6 (2023): e069014. Upadhyaya S, Kumar et al. Fibromyalgia and mental health in rheumatoid arthritis: a cross-sectional prevalence study from the COVID-19 pandemic. BMJ open 13.6 (2023): e069014.
24.
Zurück zum Zitat McFarland AJ, et al. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Rep. 2021;6:1. McFarland AJ, et al. Neurobiology of SARS-CoV-2 interactions with the peripheral nervous system: implications for COVID-19 and pain. Pain Rep. 2021;6:1.
27.
Zurück zum Zitat Minagi S, Watanabe H, Sato T, Tsuru H. Relationship between balancing-side occlusal contact patterns and temporomandibular joint sounds in humans: proposition of the concept of balancing-side protection. J Craniomandib Disord. 1990;4(4):251–6.PubMed Minagi S, Watanabe H, Sato T, Tsuru H. Relationship between balancing-side occlusal contact patterns and temporomandibular joint sounds in humans: proposition of the concept of balancing-side protection. J Craniomandib Disord. 1990;4(4):251–6.PubMed
28.
Zurück zum Zitat Blanco Aguilera A, Gonzalez Lopez L, Blanco Aguilera E, De la Aizpurua H, Rodriguez Torronteras JL, Segura Saint-Gerons A. Blanco Hungria, A. relationship between self-reported sleep bruxism and pain in patients with temporomandibular disorders. J Oral Rehabil. 2014;41:564–72.CrossRefPubMed Blanco Aguilera A, Gonzalez Lopez L, Blanco Aguilera E, De la Aizpurua H, Rodriguez Torronteras JL, Segura Saint-Gerons A. Blanco Hungria, A. relationship between self-reported sleep bruxism and pain in patients with temporomandibular disorders. J Oral Rehabil. 2014;41:564–72.CrossRefPubMed
29.
Zurück zum Zitat List T, Jensen RH. Temporomandibular disorders: old ideas and new concepts. Cephalalgia. 2017;37(7):692–704.CrossRefPubMed List T, Jensen RH. Temporomandibular disorders: old ideas and new concepts. Cephalalgia. 2017;37(7):692–704.CrossRefPubMed
38.
39.
Zurück zum Zitat Manfredini D, Arreghini A, Lombardo L, Visentin A, Cerea S, Castroflorio T, Siciliani G. Assessment of anxiety and coping features in Bruxers: a portable Electromyographic and Electrocardiographic Study. J Oral Facial Pain Headache. 2016;30:249–54.CrossRefPubMed Manfredini D, Arreghini A, Lombardo L, Visentin A, Cerea S, Castroflorio T, Siciliani G. Assessment of anxiety and coping features in Bruxers: a portable Electromyographic and Electrocardiographic Study. J Oral Facial Pain Headache. 2016;30:249–54.CrossRefPubMed
40.
Zurück zum Zitat Shedden Mora M, Weber D, Borkowski S, Rief W. Nocturnal masseter muscle activity is related to symptoms and somatization in temporomandibular disorders. J Psychosom Res. 2012;73:307–12.CrossRefPubMed Shedden Mora M, Weber D, Borkowski S, Rief W. Nocturnal masseter muscle activity is related to symptoms and somatization in temporomandibular disorders. J Psychosom Res. 2012;73:307–12.CrossRefPubMed
41.
Zurück zum Zitat Canales GT, Guarda-Nardini L, Rizzatti-Barbosa CM, Conti PCR, Manfredini D. Distribution of depression, somatization and pain-related impairment in patients with chronic temporomandibular disorders. J Appl Oral Sci Rev Fob. 2019;27:20180210.CrossRef Canales GT, Guarda-Nardini L, Rizzatti-Barbosa CM, Conti PCR, Manfredini D. Distribution of depression, somatization and pain-related impairment in patients with chronic temporomandibular disorders. J Appl Oral Sci Rev Fob. 2019;27:20180210.CrossRef
43.
Zurück zum Zitat Manfredini D, Cerea S, Pavan C, Guarda-Nardini L. Personality traits are potentially associated with the presence of chronic temporomandibular joint pain in patients without effusion as determined by T-2 weighted magnetic resonance. Cranio. 2018;36(2):91–7.CrossRefPubMed Manfredini D, Cerea S, Pavan C, Guarda-Nardini L. Personality traits are potentially associated with the presence of chronic temporomandibular joint pain in patients without effusion as determined by T-2 weighted magnetic resonance. Cranio. 2018;36(2):91–7.CrossRefPubMed
46.
Zurück zum Zitat Park J-H, et al. Pain catastrophizing for patients with temporomandibular disorders. J Oral Med Pain. 2015;40(2):47–54.CrossRef Park J-H, et al. Pain catastrophizing for patients with temporomandibular disorders. J Oral Med Pain. 2015;40(2):47–54.CrossRef
47.
Zurück zum Zitat Suvinen TI, Reade PC, Kemppainen P, Könönen M, Dworkin SF. Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain. 2005;9(6):613 – 33. https://doi.org/10.1016/j.ejpain.2005.01.012. PMID: 15978854. Suvinen TI, Reade PC, Kemppainen P, Könönen M, Dworkin SF. Review of aetiological concepts of temporomandibular pain disorders: towards a biopsychosocial model for integration of physical disorder factors with psychological and psychosocial illness impact factors. Eur J Pain. 2005;9(6):613 – 33. https://​doi.​org/​10.​1016/​j.​ejpain.​2005.​01.​012. PMID: 15978854.
Metadaten
Titel
Impact of the COVID-19 pandemic on clinical and psychological aspects of temporomandibular disorders
verfasst von
Seong Hae Kim
Bo Young Jeong
Young Sun Kim
Ji Woon Park
Publikationsdatum
01.12.2024
Verlag
BioMed Central
Erschienen in
BMC Oral Health / Ausgabe 1/2024
Elektronische ISSN: 1472-6831
DOI
https://doi.org/10.1186/s12903-024-04168-y

Weitere Artikel der Ausgabe 1/2024

BMC Oral Health 1/2024 Zur Ausgabe

„Übersichtlicher Wegweiser“: Lauterbachs umstrittener Klinik-Atlas ist online

17.05.2024 Klinik aktuell Nachrichten

Sie sei „ethisch geboten“, meint Gesundheitsminister Karl Lauterbach: mehr Transparenz über die Qualität von Klinikbehandlungen. Um sie abzubilden, lässt er gegen den Widerstand vieler Länder einen virtuellen Klinik-Atlas freischalten.

Klinikreform soll zehntausende Menschenleben retten

15.05.2024 Klinik aktuell Nachrichten

Gesundheitsminister Lauterbach hat die vom Bundeskabinett beschlossene Klinikreform verteidigt. Kritik an den Plänen kommt vom Marburger Bund. Und in den Ländern wird über den Gang zum Vermittlungsausschuss spekuliert.

Darf man die Behandlung eines Neonazis ablehnen?

08.05.2024 Gesellschaft Nachrichten

In einer Leseranfrage in der Zeitschrift Journal of the American Academy of Dermatology möchte ein anonymer Dermatologe bzw. eine anonyme Dermatologin wissen, ob er oder sie einen Patienten behandeln muss, der eine rassistische Tätowierung trägt.

Ein Drittel der jungen Ärztinnen und Ärzte erwägt abzuwandern

07.05.2024 Klinik aktuell Nachrichten

Extreme Arbeitsverdichtung und kaum Supervision: Dr. Andrea Martini, Sprecherin des Bündnisses Junge Ärztinnen und Ärzte (BJÄ) über den Frust des ärztlichen Nachwuchses und die Vorteile des Rucksack-Modells.

Update Zahnmedizin

Bestellen Sie unseren kostenlosen Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.